The actual test of stem cell therapies for Parkinsons will be whether cell transplants can provide sustained dopamine production and related symptom relief over many years
Supporting peptides like Epitalon work at the telomere level to support cellular longevity
Clinical Benefits & Side Effects Observations from Phase 2 human clinical trials
A 2025 systematic review of the musculoskeletal literature found that BPC-157 improved outcomes in muscle, tendon, ligament, and bone injury models, while noting that the evidence comes largely from animal studies [1]
Peptide Education 5-Amino-1MQ Human Clinical Trials: 2026 Status and Fat Loss Mechanism Newtropin What 5-Amino-1MQ Is 5-Amino-1-methylquinolinium iodide (5-amino-1MQ) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT)
It also modulates metalloproteinase (MMP) activity and their inhibitors (TIMPs), influencing not just the production of new matrix but the breakdown and remodeling of existing tissue